JP2011528668A - 骨関節炎を処置するための組成物および方法 - Google Patents

骨関節炎を処置するための組成物および方法 Download PDF

Info

Publication number
JP2011528668A
JP2011528668A JP2011518960A JP2011518960A JP2011528668A JP 2011528668 A JP2011528668 A JP 2011528668A JP 2011518960 A JP2011518960 A JP 2011518960A JP 2011518960 A JP2011518960 A JP 2011518960A JP 2011528668 A JP2011528668 A JP 2011528668A
Authority
JP
Japan
Prior art keywords
animal
genes
sample
composition
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011518960A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011528668A5 (https=
Inventor
ヤムカ，ライアン・マイケル
フランツ，ノーラン・ゼブロン
ガオ，シャンミン
アル・マーラニ，サマー
Original Assignee
ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヒルズ・ペット・ニュートリシャン・インコーポレーテッド filed Critical ヒルズ・ペット・ニュートリシャン・インコーポレーテッド
Publication of JP2011528668A publication Critical patent/JP2011528668A/ja
Publication of JP2011528668A5 publication Critical patent/JP2011528668A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2011518960A 2008-07-18 2009-07-20 骨関節炎を処置するための組成物および方法 Pending JP2011528668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8218508P 2008-07-18 2008-07-18
US61/082,185 2008-07-18
PCT/US2009/051169 WO2010009474A1 (en) 2008-07-18 2009-07-20 Compositions and methods for treating osteoarthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014167333A Division JP6047128B2 (ja) 2008-07-18 2014-08-20 骨関節炎を処置するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2011528668A true JP2011528668A (ja) 2011-11-24
JP2011528668A5 JP2011528668A5 (https=) 2012-08-30

Family

ID=41059867

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011518960A Pending JP2011528668A (ja) 2008-07-18 2009-07-20 骨関節炎を処置するための組成物および方法
JP2014167333A Expired - Fee Related JP6047128B2 (ja) 2008-07-18 2014-08-20 骨関節炎を処置するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014167333A Expired - Fee Related JP6047128B2 (ja) 2008-07-18 2014-08-20 骨関節炎を処置するための組成物および方法

Country Status (12)

Country Link
US (1) US9629382B2 (https=)
EP (1) EP2323638B1 (https=)
JP (2) JP2011528668A (https=)
CN (1) CN102159197A (https=)
AU (1) AU2009270718B2 (https=)
BR (1) BRPI0915986A2 (https=)
CA (1) CA2731067C (https=)
DK (1) DK2323638T3 (https=)
ES (1) ES2480193T3 (https=)
RU (1) RU2619553C2 (https=)
WO (1) WO2010009474A1 (https=)
ZA (1) ZA201101055B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014237709A (ja) * 2008-07-18 2014-12-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 骨関節炎を処置するための組成物および方法
JP2018505759A (ja) * 2015-01-06 2018-03-01 バートン，デイビット 携帯装着可能監視システム

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110159500A1 (en) * 2009-12-29 2011-06-30 Hill's Pet Nutrition, Inc. Compositions including ginger for the amelioration or prevention of inflammatory conditions
CN102138961A (zh) * 2010-02-02 2011-08-03 北京绿色金可生物技术股份有限公司 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用
CA2795575C (en) * 2010-05-12 2017-02-28 Hill's Pet Nutrition, Inc. Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
BR112012025772A2 (pt) * 2010-05-12 2015-09-22 Hills Pet Nutrition Inc métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação
WO2011143102A1 (en) * 2010-05-12 2011-11-17 Hill's Pet Nutrition, Inc. Methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in felines
US20130263294A1 (en) * 2010-09-20 2013-10-03 Bioiberica, S.A. Markers for joint displasia, osteoarthritis and conditions secondary thereto
WO2012150504A1 (en) * 2011-05-05 2012-11-08 Life Science Nutrition As Performance enhancing compositions and methods of use
BR112014007947A2 (pt) * 2011-10-03 2017-04-18 Univ Los Andes método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
CN104039823A (zh) 2011-12-19 2014-09-10 希尔氏宠物营养品公司 用于诊断和治疗伴侣动物的甲状腺机能亢进的组合物和方法
US20140220006A1 (en) * 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers
PL3280423T3 (pl) * 2015-04-08 2023-12-27 Microvascular Health Solutions, LLC Kompozycje i sposoby do synergistycznego leczenia glikokaliksu
EP3446127A4 (en) * 2016-04-20 2020-01-22 Crescendo Bioscience, Inc. BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE TREATMENT
US20190316096A1 (en) * 2016-12-28 2019-10-17 Kyowa Hakko Kirin Co Method for selecting cell
EP3612570A4 (en) 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
CN107412240A (zh) * 2017-07-24 2017-12-01 冯纪敏 一种组合物及其应用
AU2017440239B2 (en) * 2017-11-17 2021-06-24 Hill's Pet Nutrition, Inc. Compositions comprising omega-3 polyunsaturated and medium chain fatty acids
JP7402225B2 (ja) 2018-05-11 2023-12-20 ロード アイランド ホスピタル ヌクレオシド系逆転写酵素阻害剤を用いて関節障害を処置するための組成物および方法
CN109266738A (zh) * 2018-11-19 2019-01-25 山西中医药大学 类风湿关节炎大鼠炎症因子检测引物及其方法
CN109680046B (zh) * 2019-01-17 2021-08-10 浙江大学 骨关节炎第一亚型的生物标记物以及用途
CN109965124A (zh) * 2019-03-29 2019-07-05 华熙生物科技股份有限公司 一种宠物食品及其制备方法
CN110511937B (zh) * 2019-08-05 2021-07-09 华南农业大学 Snf7基因及其防治瓢虫的应用
US20230030915A1 (en) * 2019-12-16 2023-02-02 Hill's Pet Nutrition, Inc. Pet Food Compositions
US20240382518A1 (en) * 2021-09-17 2024-11-21 Seoul National University R&Db Foundation Pharmaceutical composition and health functional food for prevention or treatment of osteoarthritis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000053569A (ja) * 1998-03-19 2000-02-22 Sigma-Tau Healthscience Spa 変性または炎症性関節障害の予防的および治療的処置のための栄養補助物または医薬組成物の形態における組み合わせ組成物
WO2007002837A2 (en) * 2005-06-29 2007-01-04 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatement of inflammatory disease
JP2007502276A (ja) * 2003-08-11 2007-02-08 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 犬の変形性関節症の治療のためのオメガ−３脂肪酸
JP2008504336A (ja) * 2004-07-01 2008-02-14 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
PL346860A1 (en) * 1998-09-08 2002-03-11 Monsanto Co Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
US20020099032A1 (en) * 2000-11-10 2002-07-25 Kiyotsugu Higashi Preparations and method of producing the same
WO2005000331A2 (en) * 2003-06-04 2005-01-06 Mucosal Therapeutics, Inc. Compositions for the treatment and prevention of degenerative joint disorders
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8377904B2 (en) * 2004-02-09 2013-02-19 Hill's Pet Nutrition, Inc. Composition and method for use in cartilage affecting conditions
CN102784396B (zh) * 2004-11-09 2015-07-29 希尔氏宠物营养品公司 抗氧化剂用于基因调节的用途
JP2009522553A (ja) * 2005-12-28 2009-06-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 体重状態または素因の診断方法
US8021659B2 (en) * 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
US9629382B2 (en) 2008-07-18 2017-04-25 Hill's Pet Nutrition, Inc. Compositions and methods for treating osteoarthritis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000053569A (ja) * 1998-03-19 2000-02-22 Sigma-Tau Healthscience Spa 変性または炎症性関節障害の予防的および治療的処置のための栄養補助物または医薬組成物の形態における組み合わせ組成物
JP2007502276A (ja) * 2003-08-11 2007-02-08 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 犬の変形性関節症の治療のためのオメガ−３脂肪酸
JP2008504336A (ja) * 2004-07-01 2008-02-14 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤
WO2007002837A2 (en) * 2005-06-29 2007-01-04 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatement of inflammatory disease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014237709A (ja) * 2008-07-18 2014-12-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 骨関節炎を処置するための組成物および方法
JP2018505759A (ja) * 2015-01-06 2018-03-01 バートン，デイビット 携帯装着可能監視システム
JP7421262B2 (ja) 2015-01-06 2024-01-24 バートン，デイビット 携帯装着可能監視システム

Also Published As

Publication number Publication date
US20110183006A1 (en) 2011-07-28
JP2014237709A (ja) 2014-12-18
US9629382B2 (en) 2017-04-25
EP2323638B1 (en) 2014-05-07
AU2009270718B2 (en) 2012-09-06
EP2323638A1 (en) 2011-05-25
WO2010009474A1 (en) 2010-01-21
ZA201101055B (en) 2014-07-30
RU2619553C2 (ru) 2017-05-16
ES2480193T3 (es) 2014-07-25
BRPI0915986A2 (pt) 2015-11-03
CA2731067A1 (en) 2010-01-21
JP6047128B2 (ja) 2016-12-21
CN102159197A (zh) 2011-08-17
AU2009270718A1 (en) 2010-01-21
RU2011106033A (ru) 2012-08-27
CA2731067C (en) 2013-10-01
DK2323638T3 (da) 2014-08-11

Similar Documents

Publication Publication Date Title
JP6047128B2 (ja) 骨関節炎を処置するための組成物および方法
EP2315532B1 (en) Compositions and methods for treating disorders associated with overweight animals
RU2612901C2 (ru) Композиции и способы диагностики и лечения гипертиреоза у животных-компаньонов
Ali et al. Integrated analysis of lncRNA and mRNA expression in rainbow trout families showing variation in muscle growth and fillet quality traits
US9255296B2 (en) Compositions and methods for diagnosing and treating kidney disorders in a feline
Moran et al. Transcriptomics of liver and muscle in Holstein cows genetically divergent for fertility highlight differences in nutrient partitioning and inflammation processes
AU2010318703B2 (en) Heart aging biomarkers and methods of use
Sangalli et al. Characterization of histone lysine β‐hydroxybutyrylation in bovine tissues, cells, and cumulus–oocyte complexes
JP2009528064A (ja) クラス予測子を用いて肥満動物および痩身動物を同定する方法
Rebel et al. Maternal diet influences gene expression in intestine of offspring in chicken (Gallus gallus)
Surlis et al. Effects of dietary n-3-PUFA supplementation, post-insemination plane of nutrition and pregnancy status on the endometrial transcriptome of beef heifers
Hines et al. The impact of dietary supplementation of arginine during gestation in a commercial swine herd: I. Gilt reproductive performance
Keady et al. Effect of sire breed and genetic merit for carcass weight on the transcriptional regulation of the somatotropic axis in longissimus dorsi of crossbred steers
Ahmad Long-term molecular and functional programming of adipose tissue by pre-and early postnatal malnutrition in a precocial sheep model
Hounkpêvi et al. Influence of zinc sulfate and threonine supplementation on mucin 5ac gene expression in the small intestine and intestinal mucosal morphology in broiler chickens
Otto et al. Effect of supplementation with crude degummed canola oil on the expression of fat-related genes involved in reproduction and lipogenesis in primiparous Holstein-Friesian dairy cows in a pasture-based system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131023

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140122

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140220

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140421

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20160413